Fermenta Biotech Reports Strong Q1 EBITDA Growth to 282M Rupees
Fermenta Biotech Limited announced approval of its Q1 unaudited financial results. The company's EBITDA reached 282.00 million rupees, up from 8.00 million rupees in the same period last year. EBITDA margin improved to 20.70% from 1.03%. The board meeting was held on August 12, reviewing both standalone and consolidated operations for the quarter ended June 30. Limited Review Reports were submitted by statutory auditors SRBC & Co. LLP.
29Jul 25
Fermenta Biotech Secures European Certification for Vitamin D3 Product, Boosting Global Market Position
Fermenta Biotech Limited has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its VITADEETM 100 SD product, a spray-dried variant of Vitamin D3. The certification applies to the product manufactured at the company's Kullu, Himachal Pradesh facility. This achievement makes Fermenta one of only two companies globally to hold a CEP for this Vitamin D3 variant, reinforcing its commitment to regulatory compliance and quality standards. The certification is expected to enhance Fermenta's position in the international health and nutrition industry and expand its global presence.
29May 25
Fermenta Biotech Swings to Profit in Q4, Announces Dividend
Fermenta Biotech Ltd, a leading Vitamin D3 manufacturer, has reported a significant financial turnaround in Q4. The company posted a consolidated net profit of ₹343.90 crore, compared to a loss of ₹69.00 crore in the same period last year. Revenue increased by 44% to ₹1,400.00 crore. The board has recommended a final dividend of ₹2.50 per equity share.
Fermenta Biotech Ltd. announced impressive Q4 financial results, with revenue reaching ₹1.40 billion, up 43.89% year-over-year. The company's profitability surged, with EBITDA increasing to ₹369.40 million and net profit turning positive at ₹343.90 million, compared to a loss in the previous year. The board recommended a final dividend of ₹2.50 per equity share.